We provide a fast and reliable scale-up monoclonal antibody from transient production. Utilizing a dual high-copy vector system, F(ab)2 and Fc fragments are co-transfected into a mammalian cell line. These transfected cells are then amplified in optimized serum-free, suspension culture, and the expressed antibodies are purified with affinity chromatography. Final products are quality-tested with IgG antibody SDS-PAGE Coomassie Blue staining and ELISA. Transient antibody production has the ability to produce the desired quantity of up to 100mg within 2-3 weeks.
|
|||
|
|
|
|
![]() |
|||
|
|
||
|
|
||
|
|
Antibody Concentration versus Yield |
Production Site | Host Cell | Antibody Concentration (μg/uL) | Yield (mAb μg/Culture Sup. mL) |
|
Humanized CD3 monoclonal antibody | Other Company | 293F | 1.08 | 10 |
Abnova | 293H | 4.84 | 70 | |
293F | 1.52 | 30 |
|
|||
|
|||
Flow cytometry of human CD3 T cells stained humanized CD3 monoclonal Ab (1 µg/5*105 cells) and counterstained with PE anti-human IgG Ab (1 µg/5*105 cells). |
|||
For any inquiry, please contact : OEM@abnova.com